OBR made its first push into the north of the UK in September 2012 via Manchester. As Manchester is an important northern UK biotechnology hub, an OBR chapter here is expected to foster further growth throughout the north by initiating new networks amongst innovative individuals and promoting further bio-enterprising with the aim to rapidly expand to the many other world-class institutions in the north of the UK.
James is a second year PhD student at the University of Manchester working at the interface of chemistry and biology. Based at the Manchester Institute of Biotechnology, his research is focused on the development of novel RNA-based gene expression systems for synthetic biology applications. His interests are in technology transfer and biotech investing.
Joe obtained a BSc (Hons) class I in Biological sciences with 1year in industry at The University of Birmingham in 2011. He is currently pursuing a PhD in Stem Cell Biology at the University of Manchester focusing on the role of E-cadherin in embryonic stem cell pluripotency. Besides academic research he is interested in bio-entrepreneurship, marketing and public engagement.
Charlotte is an undergraduate student at the University of Manchester studying Biology and is looking to specialize further in her second year. Outside of science, she loves festivals, photography and would really like to visit Iceland.
Kathy is a third year PhD student at the University of Manchester, working as part of the Human Pain Research Group, based at the Salford Royal NHS Foundation Trust. Her research focuses on alleviating acute and chronic pain through EEG brain oscillatory entrainment in patients and healthy volunteers. In 2011, Kathy obtained a degree in Neuroscience BSc (Hons) from the University of Bristol. Additional interests include biotech innovation, marketing, science communication and consulting.
Peter obtained a PhD from Durham University in 2012. He is currently undertaking an EPSRC Doctoral Prize Fellowship at the University of Manchester, focusing on the development of novel luminescent biosensors based on a combination of enzymes and rare-earth upconversion nanoparticles. Besides academic research, additional interests include science communication and consulting.
John is a third year PhD student working at towards drug synthesis via enzymes in the field of biocatalysis. John’s studentship is an interdisciplinary venture with industrial partners Chirotech. His current role was preceded by a BSC (Hons) in Biological Sciences at the University of Leeds with an industrial year at Kew. His additional interested include science communication, consulting and drumming.
Yamini is a Postdoc at the University of Manchester working on an interdisciplinary project focussing on bioinformatic analysis and validation of noncoding RNA and its splicing. She completed her PhD from the School of Pharmacy and Pharmaceutical Sciences, University of Manchester, where she worked on peptide based gene delivery vectors targeting Chronic Myeloid Leukaemia. She is interested in the field of RNA therapeutics. Other than research, she is also keen on science outreach and photography.
Dr Malcolm RhodesUniversity of Manchester
Dr Rhodes' research has been the application of bioscience to the industrial production of biological medicines, with previous roles at Pfizer, Celltech (now Lonza Biologics and UCB) a number of biotech companies. In more recent years Dr Rhodes has returned to the UK as Technical Director of bioProcessUK, and has been the industrial co-ordinator of the Bioprocessing Research Industry Club, working to promote research into biopharmaceuticals. Dr Rhodes was awarded a BBSRC Industrial Impact Fellowship to work in the Centre of Excellence in Biopharmaceuticals, helping to build collaborations with companies.
Based within Manchester Business School, the Manchester Enterprise Centre is recognised as a leader in enterprise education and aims to inspire, educate and develop enterprising individuals and enable them to positively impact the growth of dynamic organisations.
Enterprise is a key part of the University of Manchester’s vision to be, ‘an innovative institution that values and encourages the transfer of knowledge and technology to influence and advance economic development regionally, nationally and internationally.’
Eric was previously Manchester Chapter president for the academic year 2012-2013.